Source: UNIV OF HAWAII submitted to NRP
GENETIC TRANSFORMATION OF SUGARCANE CHLOROPLAST TO IMPROVE EXPRESSION AND CONTAINMENT OF GENES ENCODING HUMAN VACCINES
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0208633
Grant No.
2006-34135-17707
Cumulative Award Amt.
(N/A)
Proposal No.
2006-04933
Multistate No.
(N/A)
Project Start Date
Sep 15, 2006
Project End Date
Sep 14, 2009
Grant Year
2006
Program Code
[AH]- (N/A)
Recipient Organization
UNIV OF HAWAII
3190 MAILE WAY
HONOLULU,HI 96822
Performing Department
MOLECULAR BIOSCIENCES & BIOSYSTEMS
Non Technical Summary
Rotavirus causes widespread infectious gastroenteritis in infants and farm animals, leading to high mortality. No safe vaccine is currently available and vaccine production by traditional systems is limited. This project will use a rotavirus subunit antigen that is a safe and effective vaccine. This project seeks to produce the vaccine in sugarcane plants by using a method that prevents release of a rotavirus gene into pollen and its transmission to other plants.
Animal Health Component
40%
Research Effort Categories
Basic
20%
Applied
40%
Developmental
40%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
2022020108050%
5117010104025%
7224030104025%
Goals / Objectives
The overall goal of this project is to produce a rotavirus vaccine in chloroplasts of sugarcane. The researchers will construct gene shuttle vectors for delivering the rotavirus vaccine cDNA and various reporter genes into sugarcane chloroplasts. The sugarcane chloroplast genome will be genetically transformed and screened to verify the maternal inheritance of the transgenes. Homoplasmic sugarcane plants with the highest vaccine expression will be selected. The vaccine protein will be purified for immuno-activity assays.
Project Methods
The chloroplast genome of target tissue will be engineered with the rotavirus VP6 cDNA and chloroplast promoter using homologous recombination and biolistic delivery. The VP6 cDNA will be fused with a 6X-HIS tag. Parallel experiments will use the same construct but the GFP gene will replace the rotavirus cDNA. Antibiotic-resistant sectors will be subcultured and regenerated into full plantlets by transferring calli to MS medium without 2,4-D under a 12-h light/dark condition. Antibiotic-resistant calli will also be examined for the expression of green fluorescence protein under UV light. Regenerated plantlets will also be exposed to UV light and examined by light microscopy for green fluorescence in the chloroplasts. Chloroplasts will be isolated from the leaf tissue of regenerated plants and chloroplast DNA will be purified. Southern analysis of transformed plants relative to wild type will be used to verify the insertion of foreign genes into the chloroplast DNA. To confirm the presence of the VP6 gene in homoplasmic lines, chloroplast DNA will be isolated and used for PCR analysis. Selection will be maintained and tissue sub-cultured until the homoplasmic state is obtained. Northern hybridization and RT-PCR experiments will also be conducted on chloroplast RNA to verify the presence of the full-length transcript. Detection and quantification of recombinant VP6 antigen in leaf extracts from numerous sugarcane lines, will involve using an ELISA. The plants with highest expression levels of VP6 protein will be selected for further study. Fusion of the Histidine tag to the N-terminal of VP6 gene will allow purification of the vaccine in an active form, with a single affinity purification step using nickel NTA embedded agarose beads. The purified vaccine protein will be concentrated using a Centricon-30 or Centriprep-30 unit for immunogenicity studies.

Progress 09/15/06 to 09/14/09

Outputs
OUTPUTS: The overall goal of this project is to produce a rotavirus vaccine in chloroplasts of sugarcane. The inverted repeat region of the sugarcane chloroplast DNA was identified and incorporated into the chloroplast transformation vectors. Several selectable marker expression cassettes (including aadA, confers resistance to spectinomycin and streptomycin; aphA-6, confers resistance to kanamycin and amikacin; nptII, confers resistance to kanamycin; hpt, confers resistance to hygromycin) were constructed. A rotaviral cDNA whose transcription is driven by highly active chloroplast gene promoters, translational regulatory and RNA stability regions were also incorporated into the transformation vectors. Multiple bombardments were carried out to evaluate the transformation conditions, such as biolistic delivery pressure, antibiotic selection level and interval. Several experiments of transformation using chloroplast transformation vectors were conducted via particle bombardment of embryonic calli, derived from a commercial sugarcane variety, H65-4671. The bombarded embryonic calli were selected using kanamycin or hygromycin for at least three cycles with a one-month interval. The selected embryogenic calli survived on the selection medium were micropropagated for obtaining materials for further analysis. PCR using primers based on the inverted repeat region and selectable markers were carried out, however, the PCR results were inconclusive due to either non-transformed escapes resulted from low selection pressure or the heteroplasmic nature of the chloroplast population due to low copies of transgene. We have also used the project in a demonstration for the Advances in Biosciences Education workshop for community college faculty and students in Hawaii. PARTICIPANTS: Dr. Christen Y. Yuen, Post-doctoral Research Associate, Dept. Molecular Biosciences & Bioengineering, University of Hawaii Dr. David Christopher, Professor, Dept. Molecular Biosciences & Bioengineering, University of Hawaii Dr. Y. Judy Zhu, Hawaii Agricultural Research Center, Aiea, Hawaii TARGET AUDIENCES: Plant and medical biologists and industries interested in safe vaccine development. All scientists interested in keeping transgenes and GMOs out of pollen. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts
Genetically engineered plants have great potential in agriculture to reduce the use of harmful pesticides and to produce high value compounds in safer and economical ways. However, perceived risks associated with genetic modification have led to restrictions, lawsuits and rejection of genetically altered crops. Hence, some of the important benefits that these crops offer to society may go unrealized. One major concern was that modified DNA will escape into the environment through pollen. In this project, a chloroplast transformation was attempted to produce human vaccines in sugarcane chloroplasts, which will reduce the environmental risk associated with dispersal of genetically modified DNA in pollen. The vaccine chosen was for rotavirus, which causes widespread infectious gastroenteritis in infants and farm animals. The rotavirus subunit antigen employed here is a safe an effective vaccine for immunization against the disease, however production by traditional systems is limited. Moreover, a previously developed vaccine made from attenuated whole virus has been discommended. Therefore, there is a need for large-scale production of a safe subunit vaccine. Sugarcane was chosen because the highest levels of photosynthetic productivity of any plant have been measured in sugarcane in Hawaii. This productivity and the strong protein synthesizing capacity of chloroplasts are expected to enhance vaccine production. The chloroplast transformation system which we attempt to develop in this work can also be expanded to produce other high value compounds in sugarcane.

Publications

  • No publications reported this period


Progress 09/15/07 to 09/14/08

Outputs
OUTPUTS: Several kanamycin and hygromycin resistant lines are being screened at the calli level. However, none are streptomycin resistant, meaning that the transgene may not have entered the chloroplast. The main outputs are the final characterization of these lines for the presence of the rotaviral transgene and production of vaccine protein PARTICIPANTS: Chris Yuen, post-doctoral scientist University of Hawaii David Christopher, professor, University of Hawaii Y. Judy Zhu, Hawaii Agricultural Research Center TARGET AUDIENCES: Scientists working on chloroplast molecular biology in industry and pharmaceutical companies working on vaccine development. PROJECT MODIFICATIONS: Nothing significant to report during this reporting period.

Impacts
This new technology will boost production of rotavirus vaccine that is stable and does not require refrigeration. Traditional production methods of the rotavirus vaccine have been problematic and have given poor yields. The vaccine produced in sugarcane plants is safe as a human vaccine for use in immunization of infants against dysentery, a life-threatening disease of the tropics. In addition, the vaccine can be used for protection of farm animals. Furthermore, the use of chloroplast transformation will prevent the spread of bioengineered genes in the pollen, so sugarcane can be grown large-scale in the field. The vaccine-producing sugarcane plants will provide a valuable and safe alternative crop for Hawaii agriculture.

Publications

  • No publications reported this period


Progress 09/15/06 to 09/14/07

Outputs
OUTPUTS: Because of competition with a research group in Australia, we have not publicly discussed our results and outputs. We have used the project in a demonstration for the Advances in Biosciences Education workshop for community college faculty and students in Hawaii. We described how the method of chloroplast transformation is being applied to sugarcane to express a vaccine protein against the dysentery-causing rotavirus. Chloroplast transformation is attractive because it will generate high levels of vaccine protein and does not lead to the spread of genetically engineered DNA into pollen. Since chloroplast transformation has not been reported in sugarcane, it is being developed from inception in this project. The inverted repeat region of the sugarcane chloroplast DNA was identified and incorporated into the chloroplast transformation vectors. Selectable marker expression cassettes (aadA, confers resistance to spectinomycin and streptomycin); aphA-6, confers resistance to kanamycin and amikacin; nptII, confers resistance to kanamycin; hpt, confers resistance to hygromycin), a rotaviral cDNA whose transcription is driven by highly active chloroplast gene promoters, translational regulatory and RNA stability regions were also added to the vector. Chloroplast transformation is being conducted via particle bombardment of embryonic calli. PARTICIPANTS: David A. Christopher (professor, principal investigator), University of Hawaii, CTAHR, Dept. MBBE. Yun Judy Zhu (co-principal investigator), Hawaii Agricultural Research Center, Affiliated graduate faculty MBBE. Christen Yuen (post-doctoral junior researcher), University of Hawaii, CTAHR, Dept. MBBE. TARGET AUDIENCES: American Society of Plant Biologists, NATO, United Nations

Impacts
This technology will help increase the number of doses of safe vaccine available to decrease the incidence of rotaviral-induced dysentery. Traditional production methods of the rotavirus vaccine have been problematic and have given poor yields. The new approach outlined in this project involves expression of a rotaviral coat protein antigen in sugarcane chloroplasts. This will allow maximal production of a safe supply of this human vaccine for use in immunization of infants against dysentery, a life-threatening disease of the tropics. In addition, the vaccine can be used for protection of farm animals. Furthermore, the use of chloroplast transformation will prevent the spread of bioengineered genes in the pollen, so sugarcane can be grown large-scale in the field. The vaccine-producing sugarcane plants will provide a valuable and safe alternative crop for Hawaii agriculture.

Publications

  • No publications reported this period